Open Government Portal
Found 10 records similar to Government of Canada's research response to COVID-19
Several different types of treatments for COVID-19 have been developed. Examples include drugs that reduce or stop the virus from multiplying in human cells and drugs that treat the symptoms of COVID-19.
What you, and what communities can do to lower the spread of COVID-19 in settings including social services, workplaces, outdoors, community, religious, transport and remote and Indigenous communities.
How Health Canada is addressing clinical trials of drugs and vaccines, its expedited review process and the Special Access Program to find therapies to prevent or treat COVID-19.
Many potential drugs and treatments for use against COVID-19 are being evaluated in Canada and around the world. Several different types of treatments have been developed.
The COVID-19 Emergency Loan Program for Canadians Abroad is a temporary financial assistance program to help Canadians travelling outside Canada to return home or to shelter in place while they arrange to return to Canada. This dataset provides information on the number and value of loans issued by country.
COVID-19 vaccine ingredients in the Pfizer-BioNTech, Moderna and AstraZeneca vaccines.
Mathematical modelling of COVID-19 pandemic which uses mathematical equations to estimate how many cases of a disease may occur in the coming weeks or months.
This page presents detailed information on Canada's whole-of-government actions to respond to the COVID-19 outbreak.
Parents, caregivers and children across the country are facing new challenges as the COVID-19 pandemic affects our daily work and home routines. Schools, daycares and most workplaces have closed, and children and parents are suddenly at home full-time.
Currently there are no therapies available for either the prevention or treatment of COVID-19. Health Canada is closely tracking all potential therapeutic treatments and vaccines in development in Canada and abroad, including products that are being used off-label. The Department is working with vaccine developers, researchers, and manufacturers to help expedite the development and availability of medical products such as vaccines, antibodies, and drugs to prevent and treat COVID-19.